The Propecia brand is now the property of pharmaceutical company Organon, a Merck spinoff, which told us they maintain the medication is safe. The CBC/Radio-Canada investigation found that Merck ...

European regulators are considering withdrawing market authorizations for certain hair loss and enlarged prostate treatments, including Organon’s (NYSE:OGN) Propecia, over concerns they can ...